Biocept Receives $19,000,000 New Funding

  • Feed Type
  • Date
    2/6/2014
  • Company Name
    Biocept
  • Mailing Address
    5810 Nancy Ridge Drive San Diego, CA 92121
  • Company Description
    Biocept (NASDAQ: BIOC) is a leader in genetic testing. The company’s proprietary CEE Cell Enrichment and Extraction technology is designed to isolate and extract rare cells for highly accurate genetic analysis. CEE will be used exclusively in Biocept Laboratories’ first product, preCEEd prenatal diagnostic.
  • Website
    http://www.biocept.com
  • Transaction Type
    IPO
  • Transaction Amount
    $19,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

By posting a comment, you agree to our terms and conditions.